Abstract
Transplantation of whole pancreas can restore euglycemia in patients with insulin-dependent, type 1 diabetes (T1D). It reverses diabetes in most patients, improving complications and quality of life, but requires chronic immunosuppression. Given the side effects and health risks associated with immunosuppression, exogenous insulin therapy remains the mainstay of treatment for most patients with T1D, unless patients cannot adequately control their metabolism with exogenous insulin or develop life-threatening complications (such as severe hypoglycemia and kidney failure) that can be corrected by transplantation. Pancreas transplantation (PT) is presently associated with excellent graft survival and function but requires surgery with the risk of perioperative mortality and morbidity. Thus, clinical indications and patient selection are very important. Patients with end-stage renal disease are candidates for simultaneous kidney-pancreas transplantation, which accounts for the majority of pancreas transplants. This chapter will review the current status of PT and discuss major challenges and future directions.
| Original language | English (US) |
|---|---|
| Title of host publication | Regenerative Medicine Applications in Organ Transplantation |
| Publisher | Elsevier Inc. |
| Pages | 563-570 |
| Number of pages | 8 |
| ISBN (Print) | 9780123985231 |
| DOIs | |
| State | Published - Jan 1 2014 |
| Externally published | Yes |
Fingerprint
Keywords
- Autoimmunity
- Immunosuppression
- Pancreas transplantation
- Rejection
- Type 1 diabetes
ASJC Scopus subject areas
- Biochemistry, Genetics and Molecular Biology(all)
Cite this
Current Status of Pancreas Transplantation. / Ciancio, Gaetano; Sageshima, Junichiro; Chen, Linda; Pugliese, Alberto; Burke, George W.
Regenerative Medicine Applications in Organ Transplantation. Elsevier Inc., 2014. p. 563-570.Research output: Chapter in Book/Report/Conference proceeding › Chapter
}
TY - CHAP
T1 - Current Status of Pancreas Transplantation
AU - Ciancio, Gaetano
AU - Sageshima, Junichiro
AU - Chen, Linda
AU - Pugliese, Alberto
AU - Burke, George W.
PY - 2014/1/1
Y1 - 2014/1/1
N2 - Transplantation of whole pancreas can restore euglycemia in patients with insulin-dependent, type 1 diabetes (T1D). It reverses diabetes in most patients, improving complications and quality of life, but requires chronic immunosuppression. Given the side effects and health risks associated with immunosuppression, exogenous insulin therapy remains the mainstay of treatment for most patients with T1D, unless patients cannot adequately control their metabolism with exogenous insulin or develop life-threatening complications (such as severe hypoglycemia and kidney failure) that can be corrected by transplantation. Pancreas transplantation (PT) is presently associated with excellent graft survival and function but requires surgery with the risk of perioperative mortality and morbidity. Thus, clinical indications and patient selection are very important. Patients with end-stage renal disease are candidates for simultaneous kidney-pancreas transplantation, which accounts for the majority of pancreas transplants. This chapter will review the current status of PT and discuss major challenges and future directions.
AB - Transplantation of whole pancreas can restore euglycemia in patients with insulin-dependent, type 1 diabetes (T1D). It reverses diabetes in most patients, improving complications and quality of life, but requires chronic immunosuppression. Given the side effects and health risks associated with immunosuppression, exogenous insulin therapy remains the mainstay of treatment for most patients with T1D, unless patients cannot adequately control their metabolism with exogenous insulin or develop life-threatening complications (such as severe hypoglycemia and kidney failure) that can be corrected by transplantation. Pancreas transplantation (PT) is presently associated with excellent graft survival and function but requires surgery with the risk of perioperative mortality and morbidity. Thus, clinical indications and patient selection are very important. Patients with end-stage renal disease are candidates for simultaneous kidney-pancreas transplantation, which accounts for the majority of pancreas transplants. This chapter will review the current status of PT and discuss major challenges and future directions.
KW - Autoimmunity
KW - Immunosuppression
KW - Pancreas transplantation
KW - Rejection
KW - Type 1 diabetes
UR - http://www.scopus.com/inward/record.url?scp=84902947276&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84902947276&partnerID=8YFLogxK
U2 - 10.1016/B978-0-12-398523-1.00038-0
DO - 10.1016/B978-0-12-398523-1.00038-0
M3 - Chapter
SN - 9780123985231
SP - 563
EP - 570
BT - Regenerative Medicine Applications in Organ Transplantation
PB - Elsevier Inc.
ER -